Cite

HARVARD Citation

    Maller, B. et al. (n.d.). Ipilimumab/Nivolumab-related Opsoclonus-Myoclonus-Ataxia Syndrome Variant in a Patient with Malignant Pleural Mesothelioma. Journal of immunotherapy. 41 (9), p. . [Online]. 
  
Back to record